These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 26100992

  • 21. Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantation.
    Killackey MT, Gondolesi GE, Liu LU, Paramesh AS, Thung SN, Suriawinata A, Nguyen E, Roayaie S, Schwartz ME, Emre S, Schiano TD.
    Transplant Proc; 2008 Jun; 40(5):1504-10. PubMed ID: 18589139
    [Abstract] [Full Text] [Related]

  • 22. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
    Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J, Burgart L, Wiesner R, Kremers W, Rosen C, Charlton MR.
    Hepatology; 2000 Nov; 32(5):1125-30. PubMed ID: 11050065
    [Abstract] [Full Text] [Related]

  • 23. Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.
    Hashimoto K, Miller C, Hirose K, Diago T, Aucejo F, Quintini C, Eghtesad B, Corey R, Yerian L, Lopez R, Zein N, Fung J.
    Clin Transplant; 2010 Nov; 24(5):701-8. PubMed ID: 20047619
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hepatic parenchymal changes and histologic eosinophilia as predictors of subsequent acute liver allograft rejection.
    Demirhan B, Bilezikçi B, Haberal AN, Sevmiş S, Arat Z, Haberal M.
    Liver Transpl; 2008 Feb; 14(2):214-9. PubMed ID: 18236397
    [Abstract] [Full Text] [Related]

  • 26. [Pathologic diagnosis of 1123 post-transplant liver biopsies from 665 liver transplant patients].
    Cong WM, Zhang SY, Wang ZL, Xue L, Liu YS, Zhang SH.
    Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):716-9. PubMed ID: 16536315
    [Abstract] [Full Text] [Related]

  • 27. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation.
    Regev A, Molina E, Moura R, Bejarano PA, Khaled A, Ruiz P, Arheart K, Berho M, Drachenberg CB, Mendez P, O'Brien C, Jeffers L, Tzakis A, Schiff ER.
    Liver Transpl; 2004 Oct; 10(10):1233-9. PubMed ID: 15376303
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Graft loss following liver transplantation in patients with chronic hepatitis C.
    Rosen HR, O'Reilly PM, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, Martin P.
    Transplantation; 1996 Dec 27; 62(12):1773-6. PubMed ID: 8990361
    [Abstract] [Full Text] [Related]

  • 30. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R.
    N Engl J Med; 1996 Mar 28; 334(13):815-20. PubMed ID: 8596547
    [Abstract] [Full Text] [Related]

  • 31. Role of mannose-binding lectin-2 polymorphism in the development of acute cellular rejection after transplantation for hepatitis C virus-induced liver disease.
    Eurich D, Boas-Knoop S, Yahyazadeh A, Neuhaus R, Somasundaram R, Ruehl M, Puhl G, Neuhaus P, Neumann UP, Bahra M.
    Transpl Infect Dis; 2012 Oct 28; 14(5):488-95. PubMed ID: 22650645
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hepatitis C virus recurrence in living donor liver transplant recipients.
    Rodriguez-Luna H, Vargas HE, Sharma P, Ortiz J, De Petris G, Balan V, Byrne T, Moss A, Mulligan D, Rakela J, Douglas DD.
    Dig Dis Sci; 2004 Jan 28; 49(1):38-41. PubMed ID: 14992432
    [Abstract] [Full Text] [Related]

  • 36. Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation.
    Asaoka T, Kato T, Marubashi S, Dono K, Hama N, Takahashi H, Kobayashi S, Takeda Y, Takemasa I, Nagano H, Yoshida H, Ruiz P, Tzakis AG, Matsubara K, Monden M, Doki Y, Mori M.
    Liver Transpl; 2009 Dec 28; 15(12):1738-49. PubMed ID: 19938108
    [Abstract] [Full Text] [Related]

  • 37. Results of live donor liver transplantation in patients with hepatitic C virus infection: the HCV 3 trial experience.
    Sher L, Jennings L, Rudich S, Alexopoulos SP, Netto G, Teperman L, Kinkhabwala M, Brown RS, Pomfret E, Klintmalm G, HCV-3 Study Group.
    Clin Transplant; 2012 Dec 28; 26(3):502-9. PubMed ID: 22151078
    [Abstract] [Full Text] [Related]

  • 38. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
    Eurich D, Bahra M, Boas-Knoop S, Lock JF, Golembus J, Neuhaus R, Neuhaus P, Neumann UP.
    Liver Transpl; 2011 Mar 28; 17(3):279-88. PubMed ID: 21384510
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.